On Monday, Noble Corporation plc (NYSE:NE)’s shares surged 1.36% to $16.45, as an offshore drilling contractor declared it plans to report financial results for the first quarter 2015 on Wednesday, April 29, 2015, after the close of trading on the New York Stock Exchange. Copies of the Company’s press release will be accessible on the Noble Web site at www.noblecorp.com.
Noble also has planned a conference call and webcast related to its first quarter 2015 results on Thursday, April 30, 2015, at 8:00 a.m. U.S. Central Daylight Time. Interested parties are invited to listen to the call by dialing 1-866-461-7129, or internationally 1-706-679-3084, using access code: 61264943, or by asking for the Noble Corporation conference call. Interested parties may also listen over the Internet through a link posted in the Investor Relations section of the Company’s Web site.
Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units. As of December 31, 2014, the company operated a fleet of 15 jackups, 9 drillships, and 8 semisubmersibles, counting 1 high-specification, harsh environment jackup under construction. Noble Corporation plc was founded in 1921 and is headquartered in London, United Kingdom.
Citizens Financial Group, Inc. (NYSE:CFG)’s shares gained 1.35% to $25.45, during the last trading session on Monday, as on April 2, Citizens Bank declared the launch of the Citizens Bank Student Loan for ParentsTM, a new alternative to federal loans for parents who are assisting students pay for college. With no origination fee, the Student Loan for Parents will save families an estimated average of $6271 in annual fees alone and also guarantees approved borrowers receive a lower interest rate than the federal William D. Ford Direct PLUS rate.
The new loan is the latest offering from Citizens Bank designed to assist people pay for higher education in a more affordable way, and furthers Citizens’ Bank Better commitment to make banking simple, clear and personal for consumers. In addition, the Student Loan for Parents is an option for anyone who is looking to assist a student finance their education, allowing parents or other sponsors to finance a student’s education without obligating the student to the debt.
Last year, parents spent an estimated $400 million dollars in origination fees through the William D. Ford Direct PLUS loan program. With no origination fees and rates as low as 6.60 percent when borrowers take advantage of rate-reducing benefits, the Citizens Bank Student Loan for Parents offers borrowers an attractive alternative. In addition to an improved interest rate, borrowers of the Citizens Bank Student Loan for Parents can save an average of $627 every year simply by avoiding the Federal Direct PLUS loan’s annual origination fee. The loan is accessible in multiple repayment terms. In the event the parent does not qualify, Citizens Bank will redirect the customer back to the PLUS program ensuring the family always has the information they need to make the best loan decision.
The Student Loan for Parents is the latest offering from Citizens Bank which also offers the Citizens Bank Student Loan (formerly known as the TruFit Student Loan) and the Citizens Bank Education Refinance LoanTM, which enables borrowers to refinance federal and private student loans. Since launching the Citizens Bank Education Refinance Loan last year, the average customer savings is $145 a month, meaning customers are saving thousands of dollars in interest payments over the life of their loans.
Citizens Financial Group, Inc. operates as the bank holding company for Citizens Bank, N.A. and Citizens Bank of Pennsylvania that provide retail and commercial banking products and services in the United States. It operates through two segments, Consumer Banking and Commercial Banking.
At the end of Monday’s trade, KeyCorp. (NYSE:KEY)’s shares gained 1.35% to $14.25, as on April 7, Acuity Brands, Inc. (AYI) and Key Equipment Finance recently declared that the two companies have teamed up to provide flexible financing solutions to qualified Acuity Brands customers converting to energy-efficient LED lighting and installing smart lighting networks. Key Equipment Finance is one of the largest bank-held equipment finance companies in the U.S. and an associate of KeyCorp (KEY).
The arrangement will provide customers of Acuity Brands — a leading provider of indoor and outdoor LED lighting solutions — with flexible financing options that cover the total cost of upgrading to an energy-efficient LED smart lighting network that may comprise a platform for connecting to the Industrial Internet of Things (IIoT). By doing so, customers can take full advantage of Acuity Brands` LED lighting and controls solutions, which can comprise installation, design and layout, training, commissioning of networked lighting controls, maintenance and other soft costs. Financing with Key Equipment Finance also gives customers the ability to conserve cash and take advantage of the benefits and flexibility of financing capital equipment.
Customers who may want to take advantage of this opportunity comprise those managing qualified municipalities, industrial complexes, educational institutions, healthcare facilities and other businesses that may benefit from financing into one, predictable monthly payment for the complete bundle of services and products from Acuity Brands.
KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States.
Finally, Isis Pharmaceuticals, Inc. (NASDAQ:ISIS), ended its Monday’s trading session with 1.34% gain, and closed at $66.58, after the leader in antisense therapeutics, declared that administration will present a company overview at the following investor conferences:
- 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 in New York, NY;
- 40th Annual Deutsche Bank Health Care Conference on Thursday, May 7, 2015 in Boston, MA;
- 2015 Bank of America Merrill Lynch Health Care Conference on Tuesday, May 12, 2015 in Las Vegas; and
- 2015 UBS Global Healthcare Conference on Tuesday, May 19, 2015 in New York, NY.
Isis Pharmaceuticals, Inc. engages in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product comprises the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients with homozygous familial hypercholesterolemia; and for the reduction of low-density lipoprotein cholesterol. It also has a pipeline of 38 drugs in development for the treatment of various diseases, counting cardiovascular and metabolic diseases; severe and rare diseases, which comprise neurological disorders; and cancer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
